UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read moreFri, 30th Oct 2009 06:11
UK Earnings, Trading Statements Calendar - Next 7 Days
Read moreEvgen Pharma, Rochester University To Advance SFX-01 For Trial
Read moreEvgen Pharma Hails "Positive" Data From Breast Cancer Drug Research
Read more(Sharecast News) - Evgen Pharma on Tuesday reported a narrowed interim loss and said it was confident of clinical success as it continues to develop its SFX-01 treatment.
Read moreEvgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma has entered into a memorandum of understanding with the University of Dundee, it announced on Thursday, to advance SFX-01 towards a clinical trial in non-alcoholic steatohepatitis (NASH) and liver fibrosis.
Read moreEvgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials
Read moreUPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development
Read moreUK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance
Read moreEvgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results
Read moreEvgen Pharma "Delighted" With Extended Breast Cancer Treatment Results
Read more(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Monday that five patients who participated in the 'STEM' trial received 'SFX-01' treatment for more than one year, with two of those patients continuing to be treated with SFX-01.
Read more(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Wednesday that the last study visit for the last patient entered in the double-blind, placebo-controlled 'SAS' phase 2 clinical trial has taken place.
Read more(Alliance News) - Evgen Pharma PLC said Wednesday it has entered its last patient in the double-blind, placebo-controlled SAS Phase II clinical trial that is testing its SFX-01 product, aimed at a
Read more